June 10, 2026 Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
June 10, 2026 Treno Scope Announces SOC 2 Type 1 Certification, Continuing To Strengthen Trusted Web3 Data Infrastructure In The AI Era
June 10, 2026 Intel 471 Launches Free CTI Maturity Pulse Check to Amplify Program Growth and Business Value
June 10, 2026 Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia
